Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
irinotecan (Camptosar) (1 trial)
lapatinib (tykerb) (1 trial)
Glioma (Phase 2)
Trials (1 total)
Trial APIs (2 total)